|
|
UCSD-Nature Molecule Pages
Published online: 27 Nov 2007 | doi:10.1038/mp.a000228.01
Ags3
Joe B Blumer1, Motohiko Sato2, Stephen M Lanier3
1Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, SC 29425, US. 2Cardiovascular Rsch Institute, Yokohama City University Graduate School of Medicine, 236-0004, JP. 3Cell and Molecular Pharmacology, Medical University of South Carolina, SC 29425, US.
Correspondence should be addressed to Stephen M Lanier: laniersm@musc.edu

AGS3 (activator of G-protein signaling 3), or GPSM1 (NM_144745), was isolated from the neuroblastoma–glioma hybrid cell line NG108-15 by using a functional screen in a yeast strain expressing mammalian Gαi3 sequences in place of the yeast Gα to identify receptor-independent activators of heterotrimeric G-protein signaling. AGS3 (a 650 amino-acid protein) consists of two functional domains defined by a series of seven amino-terminal tetratrico peptide repeats (TPRs) and four carboxy-terminal G-protein Regulatory (GPR) or GoLoco motifs. Each of the GPR motifs binds to Giα1–3 and Gαo, whereas the TPR domain is a site for binding regulatory proteins. The interaction of GPR motifs with Gi/oα stabilizes the GDP-bound conformation of Gα and competes with Gβγ for binding to Giα. GPR peptides may promote dissociation of Gα and Gβγ independently of nucleotide exchange and can serve as alternative binding partners for αi•GDP free of Gβγ. AGS3 is a member of the Group II Activators of G-protein signaling, which possess one or more G-protein regulatory (GPR) motifs, which have revealed surprising, unpredicted, functional roles for the ‘G-switch’ in flies, worms and vertebrates. Group II AGS proteins include AGS3, AGS5 or LGN, AGS4 and AGS6 or RGS12, with GPR motifs also found in RGS14 and Pcp2/L7. AGS3, AGS5 and the Drosophila melanogaster ortholog Pins have a similar domain organization with seven tetratricopeptide repeats and up to four GPR motifs. Functional studies with these proteins indicate that their interaction with Gα and control of the ‘G-switch’ provide important signals required for asymmetric cell division, neuronal development and/or synaptic plasticity.
Alternative names for this molecule:
1810037C22Rik; Activator of G protein signaling 3; Ags3; AGS3-LONG; AGS3-SHORT; G-protein signalling modulator 1 (AGS3-like, C. elegans); Gpsm1; RIKEN cDNA 1810037C22 gene
Acknowledgments:
ACKNOWLEDGMENTS This work was supported by MH90531 (SML), NS24821 (SML). SML is greatly appreciative for support provided by the David R. Bethune/Lederle Laboratories Professorship in Pharmacology and the Research Scholar Award from Yamanouchi Pharmaceutical Company (now named Astellas Pharma Inc.).
|
|
|